Loading...
Coloplast Community
CPSE:COLO B Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 46 Fair Values set on narratives written by author
Community Investing Ideas
Chronic Care Focus And Emerging Markets Will Redefine Healthcare
Key Takeaways Strategic restructuring, targeted innovation, and successful acquisitions are strengthening growth, operational efficiency, and diversification across premium and chronic care segments. Expanding emerging market presence and user-focused product launches are driving recurring revenues, reducing regional dependence, and positioning Coloplast for sustained long-term momentum.
0users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
AN
DKK 691.83
15.4% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
6.94% p.a.
Profit Margin
20.85%
Future PE
25.96x
Share price in 2028
DKK 818.84